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Abstract.  The entry of blood-borne lymphocytes into 
most secondary lymphoid organs is initiated by a 
highly specific adhesive interaction with the special- 
ized cuboidal endothelial cells of high endothelial ven- 
ules (HEV).  The adhesive receptors on lymphocytes 
that dictate interactions with HEV in different lym- 
phoid organs are called homing receptors,  signifying 
their critical role in controlling organ-selective lym- 
phocyte migration.  Considerable work has established 
that the mouse peripheral  lymph node homing recep- 
tor (pnHR), defined by the mAb MEL-14, functions as 
a  lectin-like adhesive protein.  We have previously 
shown that sialidase treatment of peripheral  lymph 
node (PN) HEV abrogates lymphocyte attachment to 
the HEV both in vivo and in vitro. We extend this 
evidence by demonstrating  that L/max agglutinin  (LA), 
a  sialic acid-specific lectin, when reacted with HEV 
exposed in cryostat-cut tissue sections, blocks lympho- 
cyte attachment to PN HEV and, unexpectedly, to the 
HEV of Peyer's patches (PP) as well. Using a recom- 
binant form of the pnHR as a histochemical probe for 
its cognate adhesive site (HEV-ligand) on PN HEV, 
we demonstrate that both sialidase and L/max aggluti- 
nin functionally inactivate this ligand.  It is concluded 
that the requirement for sialic acid is at the level of 
the pnHR interaction with its HEV ligand.  A  distinct 
sialyloligosaccharide may encode the recognition de- 
terminant of a PP HEV ligand. 
T 
HE process of lymphocyte extravasation  into lymph 
nodes and most other secondary lymphoid organs re- 
quires that blood-borne lymphocytes first bind to the 
endothelium of specialized high walled postcapillary venules 
known  as  high  endothelial  venules  (HEV) ~ (reviewed  in 
Berg et al.,  1989;  Duijvestijn and Hamann,  1989; Rosen, 
1989; Stoolman, 1989; Woodruffet al., 1987). The selective 
interaction of lymphocytes with HEV in different anatomical 
sites is believed to play a pivotal role in the organ-selective 
migration  or  "homing"  of lymphocytes within  the  body 
(Butcher,  1986).  The  lymphocyte-associated  molecules 
responsible for organ-selective  interaction  with  HEV are 
operationally termed "homing"  receptors (Gallatin  et al., 
1986), whereas the cognate adhesion  molecules on the en- 
dothelium are referred to as "HEV-ligands" or "vascular ad- 
dressins" (Berg et al., 1989). Acting in concert with homing 
receptors are accessory molecules,  such as LFA-1, which 
augment lymphocyte adhesion to HEV but do not impart or- 
gan selectivity (Hamarm et al., 1988; Pals et al., 1988). The 
peripheral  lymph node homing  receptor (pnHR) was ini- 
tiaUy defined in the mouse by the mAb MEL-14 (Gallatin et 
al., 1983). This antibody reacts with a =90-kD surface gly- 
1. Abbreviations  used in this paper:  BSM,  bovine submaxillary  mucin; 
DBA, Dolichus biflorus agglutinin; HEV, high endothelial venules; M6P, 
mannose-6-phosphate;  LA, L/maxflavus agglutinin; PN, peripheral lymph 
node; pnHR, peripheral  lymph node homing receptor. 
coprotein (gp90  MEL) on the lymphocyte causing  a blockade 
of lymphocyte migration  to peripheral lymph nodes (PN) in 
vivo and preventing  lymphocyte attachment to PN HEV in 
the Stamper-Woodruff in vitro adherence assay  (Stamper 
and Woodruff,  1976). As further evidence for the homing 
function of gp90  u~L, both the purified  molecule (Geoffroy 
and Rosen,  1989) and a recombinant form (Watson et al., 
1990) can interact  selectively with PN HEV and block lym- 
phocyte attachment.  With respect to its mechanism of ac- 
tion,  a  substantial  body of work has now established that 
gp90  Mm and  its  human  homologue function  as  calcium- 
dependent,  lectin-like  receptors  (Stoolman  and  Rosen, 
1983; Stoolman et al.,  1984,  1987; Yednock et al.,  1987a, 
b; Brandley et al.,  1987; Stoolman and Ebling,  1989; Imai 
et al.,  1990).  Central  to this evidence are the findings that 
a limited set of anionic carbohydrates  selectively inhibit the 
adhesive  function of the homing  receptor.  The most active 
inhibitors  include marmose-6-phosphate  (M6P), fructose-I- 
phosphate,  a  M6P-rich  polysaccharide known as  PPME, 
fucose-sulfate-contalning polysaccharides (e.g., fucoidin), 
and the galactose-sulfate glycolipid known as sulfatide (Imai 
et al., 1990). In addition to these results establishing  sugar- 
selective  inhibition,  the  molecular  cloning  of  gp90  MEL 
(Lasky et al., 1989; Siegelman et al., 1989) has revealed the 
presence of a calcium-dependent (C-type) lectin motif of 117 
amino acid residues at the amino-terminal  extracellular  do- 
main of the receptor.  The epitope for the MEL-14 mAb maps 
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precedes an EGF motif, two contiguous complement-regula- 
tory motifs ("short consensus repeats"), a transmembrane do- 
main, and a short cytosolic tail. A similar organization of mo- 
tifs has  been discerned for two other adhesion molecules 
known as GMP-140 and ELAM-1 (Bevilacqua et al., 1989; 
Johnston et al.,  1989) as well as the human homologue of 
gp90  ~L (Bowen  et al.,  1989;  Camerini et ai.,  1989;  Ki- 
shimoto et al., 1990; Siegelman and Weissman, 1989; Ted- 
der et al.,  1989, 1990).  This newly defined family of cell 
adhesion receptors has been designated "LEC-CAMs" (Stool- 
man, 1989) or alternatively "selectins" (Geng et al., 1990). A 
possible role for the EGF domain in the adhesive function 
of the pnHR is implied by the recent work of Siegelman et 
al. (1990).  Three candidates (LPAM-1 antigen, gp90  x~tMEs, 
and HEBFpp) for a Peyer's patch (PP) homing receptor have 
been identified in rodents and human (Chin et al.,  1986; 
Holzmann et al., 1989; Jalkanen et al., 1986). The first two 
are not members of the LEC-CAM family, whereas the third 
requires further biochemical characterization (Chin et al., 
1986;  Goldstein et al.,  1989;  Holzmann et al.,  1989;  Sta- 
menkovic et al.,  1989). 
The evidence that the pnHR functions as a lectin has led 
to the examination of PNHEV for the presence of carbohy- 
drate-based recognition determinants. Initial studies demon- 
strated the periodate sensitivity of the adhesive sites on PN 
HEV and PP HEV, consistent with an essential role for car- 
bohydrates at both endothelial sites  (Rosen et al.,  1985; 
Rosen and Yednock,  1986). Subsequently, it was shown that 
treatment of HEV in vitro (Rosen et al.,  1985)  or in vivo 
(Rosen  et  al.,  1989)  with bacterial  sialidases  selectively 
abrogates lymphocyte attachment to PN HEV while having 
no effect on binding to PP HEV. A partial effect of sialidase 
was observed on mesenteric lymph node HEV,  consistent 
with the evidence that this endothelium expresses a mixture 
of PN- and PP-like ligands (Butcher et al., 1980; Streeter et 
al., 1988a).  In the present study, we extend the evidence that 
sialic acid is critical for the adhesive function of PN HEV 
by showing that the sialic acid-specific lectin, Limaxflavus 
agglutinin (LA), functionally  inactivate adhesive sites on PN 
HEV and, surprisingly, on PP HEV as well. Using a recom- 
binant form of pnHR as a histochemical staining reagent for 
its cognate HEV ligand, we provide direct evidence that the 
requirement for siaiic acid is at the level of  the homing recep- 
tor interaction. 
Materials and Methods 
Materials 
Biotin-caproyl lectins (peanut agglutinin [PNA], Con A, Ricinus communis 
agghitinin-I  [RCA-1], WGA) were purchased from Biomeda Corp. (Foster 
City, CA). The unconjugated lectins were obtained as follows: Con A, grade 
IV from Sigma Chemical Co.  (St.  Louis,  MO); L/maxflavus agglutihin 
(LA),  U/ex europaeus  I  (UEA-I),  and WGA from Calbiocbem-Behring 
Corp. Inc. (La Jolla, CA); Dolichos biflorus (DBA) and L/mulus polyphe- 
mus agglutinin (limulin) from Worthington Biomedicals  (Freehold, NJ); 
and PNA from Vector Laboratories (Burlingame,  CA). The principal hap- 
ten sugar-binding speciflcities of  the lectins used in this study are as follows: 
PNA (fl-D-Gal); ConA (or-o-Man, ot-~Glc); RCA-1 (fl-v-Gal); WGA (fl-D- 
GIcNAc); UEA-I (ct-L-Fuc); DBA (t~-~GalNAe); limulin (ot-NeuAc); L/- 
max agglutinin (tx-NeuAc). N-acetyi-neuraminic  acid from Escherichia coli 
(Neu5Ac), D-glucuronic acid (GIcUA), bovine submaxillary mucin (BSM), 
~galactose, or-methyl D-mannoside, and lactose were from Sigma Chemi- 
cal Co. Vibrio cholera neuraminidase (sialidase) was from Gibco Laborato- 
ries (Grand Island, NY).  CIostridium perfringens neuraminidase or siali- 
dase (Type X, attinity-purified)  was from Sigma Chemical Co.  All other 
reagents used were of analytical  quality. 
In Vitro Adherence Assay 
The  basic  Stamper-Woodruff  in  vitro  adherence  assay  (Stamper  and 
Woodruff,  1976),  which measures lymphocyte attachment to profiles  of 
HEV exposed within cryostat-cut sections of lymphoid organs, was adapted 
for the present studies.  10-/~m  cryostat sections of mouse (ICR, female) pe- 
ripheral lymph nodes and Peyer's patches were cut and fixed with parafor- 
re_aldehyde  as previously described (Stoolman et al., 1984). The tissue see- 
tions were exposed to the individual lectins: 120 ~1 at 180 #g/ml of lectin 
in TBS (50 mM Tris-HC1,  100 mM NaCI,  10 mM CaCI2, pH 7.5) for 30 
rain at 4°C. (The activity of the lectins was confirmed by hemagglutination 
assays w~th appropriate inhibition  by hapten monosaccharides or glycocon- 
jugates.) The sections were then fixed in 0.5%  glutaraldehyde  in sodium 
cacodylate buffer, (0.1 M, pH 7.3) for 20 min at 4°C followed by treatment 
with 0.2 M  lysine in TBS to block reactive aldehyde  groups.  Alkaline 
denaturation consisted of a 45-min exposure of the sections to 0.1 N NaOH 
at 4°C. After washing, the sections were then used for the in vitro adherence 
assay with test lymphocytes  harvested from mesenteric lymph nodes.  The 
lymphocyte suspension included 300/~g/ml of BSM to reduce nonspecific 
binding to the sections.  Subsequent steps of the in vitro adherence assay 
were as described before (Stoolman et al., 1984). Quantification of lympho- 
cyte binding to HEV was done by digital morp~  (Bioqnant II; R & M 
Biometrics, Nashville, TN) as detailed previously (Rosen et al., 1985). The 
results were computed as the mean number of lymphocytes bound per unit 
area. At least nine HEV segments per section were analyzed.  Four to five 
independent  tissue sections were used for each experimental condition from 
which means and SEM values were computed.  The results are presented 
as percentages of control samples,  which are set to 100%.  In one experi- 
ment, PP sections were treated with Vibrio cholera (5 Gibco units in 50 mM 
Na acetate,  100 mM NaCI,  4 mM CaC12, pH 5.5) for 30 min at 7-10°C 
before exposure to LA. The lymphocyte suspension used in this experiment 
was treated with 100 #g/ml of trypsin (T-8253; Sigma Chemical Co.) for 
15 rain at 37°C. This treatment eliminated background binding to non-HEV 
regions of PP, but did not affect the specific binding to PP HEV. 
Histochemical Staining with Biotinylated Lectins 
Paraformaldehydc-fixed tissue sections of PN and PP, prepared as described 
above, were exposed to biotinylated-lectins  (100 t~l per section at the indi- 
cated concentrations) suspended  in Dulbecco's PBS containing 5 mg/ml of 
BSA. After 45 min at 4°C, the sections  were washed and incubated with 
100 t~l of ABC-HRP reagent (Elite kit; Vector Laboratories, Burlingame, 
CA) for 30 rain at 22°C followed by development of the reaction product 
with HRP chromagen (Biomeda,  Foster City, CA) at 22°C.  After termina- 
tion of the reaction with a water rinse, the sections were eounterstained with 
aqueous hematoxylin (Biomeda) and mounted with Immu-mount (Shandon 
Instruments, Inc., Pittsburgh, PA). Specificity of staining was evaluated by 
exposing each lectin to a competive saccharide or glycoconjugate before and 
during the incubation with the tissue section. The following inhibitors were 
used:  PNA (100 mM lactose); Con A (50 mM c~-methyl v-mannoside), 
RCA-1 (500 mM 0-gaiactose) and WGA (5 mg/ml BSM). These competitors 
essentially  eliminated  staining,  by  the  biotinylated lectins  (results  not 
shown),  thus establishing that the lectins were binding to glycoconjugates 
to the sections via their sugar-binding functions. 
Histochemical Staining with Limax Agglutinin 
An antibody to LA was prepared by injecting a rabbit at multiple intrader- 
real sites with I00/~g of LA emulsified  in Freund's complete adjuvant 
(Difco Laboratories, Detroit, MI). Serum obtained 7 wk after immuniza- 
tion was  used.  IgG was  isolated using Zeta-Chrom 60D1  amine disks 
(AMF-Cuno Laboratory Products,  Meriden, CT) following the manufac- 
turer's specifications.  For staining,  paraformaldebyde-fixexl tissue sections 
were exposed to LA at 10 #g per section in PBS for 1 h at 4°C. After wash- 
ing, the sections were tw~ted with anti-LA IgG, diluted 1:500 in PBS, and 
incubated for 30 rain at 22°C, followed by additional washes, and incubation 
with biotinylated-goat  anti-rabbit IgG (Vector Laboratories), diluted 1:50 
in PBS with 5 % normal mouse serum. As described in the previous section, 
reaction product was produced with ABC-HRP and HRP chromagen, and 
counterstaining  was with aqueous hematoxylin. Without the addition of LA, 
there was no staining of the sections. As additional specificity controls, LA 
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Figure 1.  Effects of lectin pretreatment on adhesive function of 
HEV. Sections of PN and PP were treated with the indicated lectin, 
and then subjected to glutaraldehyde fixation followed by exposure 
to alkaline pH to cross-link the lectin to the tissue sections and 
inactivate unoccupied lectin-binding sites. Lymphocyte attachment 
to HEV was determined in the in vitro adherence assay and normal- 
ized to a percentage of  the control level of  binding (no added lectin). 
Absolute levels of binding in control  samples were 41  lympho- 
cytes/104 t~m  z in PN sections and 20 lymphocytes/llY t~m  2 in PP 
sections. (a) PN sections (b) PP sections. 
was mixed with 50 mM of sialic acid (Neu5Ac) before and during incubation 
with the sections, or alternatively, the sections were pretreated with Vibrio 
cholera sialidase (50 Gibco units per section in acetate buffer for 30 min 
at 7°C) just before LA addition. Both treatments substantially reduced the 
overall staining of the sections and virtually eliminated the staining of HEV. 
Histochemical Staining with the pnHR-IgG Chimera 
The chimera was produced and purified as previously described (Watson et 
al.,  1990). For enzyme treatments, paraformaldehyde-fixed sections, pre- 
pared as above, were exposed to sialidases (Vibrio cholera in 50 mM Na 
acetate,  100 mM NaCI, 4 mM CaCI2, pH 5.5 or Clostridium perfringens 
in 50 mM Na acetate,  100 mM NaC1, pH 5.0) or to the respective buffers 
alone for 30 rain at 7°C. After washing in PBS, the sections were treated 
with methanol containing 0.3% H202 for 20 min on ice. The sections were 
washed and then exposed to 6/~g per section of chimera in PBS for 20 min 
at 7°C. Reaction product was developed through sequential application of 
biotinylated-goat anti-human IgG, ABC-HRP, and HRP chromagen as de- 
scribed above. Counterstaining was with hematoxylin. For a specificity con- 
trol, some sections were treated with Vibrio cholera siaiidase plus 100 mM 
sialic acid (Neu5Ac) before staining with the chimera. For the LA experi- 
ments, paraformaldeyde-fixed sections of PN, exposed to H202 in metha- 
nol as above, were treated with the lectin (100/~1  per section, 200 ~g/ml 
in TBS) for 60 rain at 4°C. The sections were washed in PBS and reacted 
with desialylated chimera (3 #g per section) in the presence of 300/~g/ml 
of BSM. The remaining steps were as described above. Desialylated chi- 
mera was prepared by incubation with agarose-linked Clostridium neur- 
aminidase (N-4883; Sigma Chemical Co.). 45 #g of chimera in PBS was 
incubated with 0.15 IU (international units) of enzyme for 30 min at 37°C. 
The use of desialylated chimera together with BSM reduced the background 
staining resulting from binding of the chimera to LA that was associated 
with the sections. 
Results 
Effects of  Lectins on Lymphocyte Attachment Sites 
of HEV 
Lectins of defined carbohydrate specificity have been widely 
used as probes for cell surface glycoconjugates (Lis and Sha- 
ron, 1986; Nicolson, 1974). The availability of siaiic acid- 
specific lectins provided the opportunity for further study of 
the  involvement of siaiyloligosaccharides in  the  adhesive 
function of HEV. LA, isolated from the slug Limaxflavus, 
is highly specific for sialic acid in many of its naturally oc- 
curring  forms  and  linkages  (Miller,  1987;  Miller  et  ai., 
1982;  Ravindranath  et  al.,  1985;  Schulte  et  ai.,  1984; 
Wagner and Roth,  1988). LA and a series of other lectins, 
representing a wide range of carbohydrate-binding specific- 
ities (see Materials and Methods), were compared for their 
ability to inhibit the adhesive function of HEV in tissue sec- 
tions. The multivaiency of several of the lectins caused in- 
discriminate binding of lymphocytes to the tissue sections. 
It was,  therefore,  necessary to  inactivate the  unoccupied 
binding sites of these lectins, once they had bound to the tis- 
sue sections. To achieve this objective, the lectin-treated sec- 
tions were subjected to a "cross-linking and denaturation" 
procedure consisting of sequential glutaraldehyde fixation 
and alkaline denaturation. In control experiments, it was de- 
termined that this combination of treatments still permitted 
highly specific lymphocyte binding to HEV at levels close 
to those of untreated tissue sections. As  shown in Fig.  1, 
pretreatment of sections with LA (180/~g/ml) markedly re- 
duced lymphocyte attachment to both PN and PP HEV. The 
other lectins, including two that react with sialyloligosaccha- 
rides (limulin and WGA), produced no inhibition. The MEL-14 
antibody  retained  its  ability  to  inhibit  lymphocyte-HEV 
binding  after pretreatment of PN  sections  with  WGA  or 
limulin, thus establishing that the adhesive mechanism was 
not qualitatively altered by these lectins (data not shown). 
Among the inactive lectins were several (Con A, WGA, and 
RCA-1) that were able to bind to HEV as determined by 
histochemical staining (Fig. 2). If PN or PP sections were 
treated  with  LA  in  the  presence  of 50  mM  sialic  acid 
(Neu5Ac), lymphocyte attachment to HEV returned to near 
control levels, whereas coincubation with glucuronic acid 
did not abrogate the inhibitory activity of the lectin (Fig. 3). 
True et al.  Sialic Acid and HEV Adhesive Function  2759 Figure 2.  Histochemical  staining for binding of lectins to tissue sections.  PN sections (a-f) or PP sections (g and h) were reacted with 
lectins in conjunction with HRP histochemistry  as described in Materials and Methods. (a) PBS control; (b) RCA-1; (c) Con A; (d) WGA; 
and (e-h) LA. In f  and h the PN and PP sections, respectively, were pretreated with 50 Gibco units of sialidase per section before LA 
exposure. Almost complete removal of LA-reactive sites was also observed after treatment of both tissues with five units per section. In 
a, f, and h, arrowheads  delimit basement membranes of individual HEV. Bar, 20 #m. 
Lymphocyte binding to HEV was not affected by pretreat- 
ment of PN or PP sections with 50 mM sialic acid or gluc- 
uronic acid alone (data not shown). Thus, it is concluded that 
function-blocking effects of LA on HEV were occurring via 
its  sialic  acid binding  activity rather than through  a  non- 
sugar-dependent interaction of the lectin or a contaminant in 
the lectin preparation. 
It seemed plausible that the targets for LA on PN HEV 
were the  same functionally important sialic acid  moieties 
that were sensitive to bacterial sialidases (Rosen et al., 1985, 
1989). However, in the case of PP, LA blocked lymphocyte- 
HEV adhesion  despite the  fact that  sialidases  did  not  in- 
activate the PP HEV ligand.  One possible explanation was 
that LA sterically inhibited a functional site of the PP HEV 
ligand through an interaction with physically contiguous, but 
functionally irrelevant,  sialic acid moieties. 
To explore this possibility, PP sections were exposed to 
sialidase  before treatment  with  LA.  This  combination  of 
treatments produced a  level of inhibition  equivalent to the 
lectin alone (Fig. 4), even though the majority of LA-reactive 
sites were eliminated by the sialidase pretreatment (Fig. 2). 
Thus, it appears that the adhesion-blocking activity of LA on 
PP HEV is directed against sialidase-resistant residues, con- 
stituting a  minority of the total LA-reactive sites. 
Effects of  Sialidase and Limax Agglutinin on Binding 
of a Recombinant Homing Receptor Chimera to HEV 
A soluble recombinant form of the pnHR has been described 
(Watson et al.,  1990).  The molecule is a chimera of the ex- 
tracellular  domains  of gp90  MEL (lectin,  EGF  and comple- 
ment-regulatory motifs) and the constant region of human 
IgG1. The lectin activity of gp90  MEL is retained in this pnHR- 
IgG chimera, as demonstrated in an ELISA assay measuring 
the binding of the chimeric receptor to PPME (a yeast poly- 
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Figure 3. Effects of sugars on blockage of HEV adhesive sites by 
L/max agglutinin.  LA was reacted with sections of (a) PN or (b) 
PP in the presence of sialic acid (25 mM Neu5Ac), glucuronic acid 
(25 mM GIcUA), or no added sugar. The sections were processed 
and tested for lymphocyte adherence to HEV as before. Binding to 
HEV was normalized to a percentage of the control level of binding 
(no LA). Absolute levels of lymphocyte binding in control samples 
were  36  lymphocytes/104 /~m  2 in  PN  sections  and  23  lympho- 
cytes/104 #m  2 in PP sections. 
saccharide containing high levels of mannose-6-phosphate) 
(Imai et al., 1990; Watson et al., 1990). This pnHR-IgG chi- 
mera,  used  in  combination  with  a  biotinylated-goat anti- 
human  IgG and ABC-HRP,  serves as a  histochemical  re- 
agent for staining of HEV in PN (Watson et al.,  1990).  In 
correspondence with the organ selectivity of pnHR, staining 
of PP HEV is absent or is much reduced compared with that 
ofPN HEV. Moreover, the staining ofPN HEV is selectively 
blocked by MEL-14 mAb, by calcium chelation, or by the 
specific carbohydrates (e.g., fucoidin) that block lymphocyte 
attachment to PN HEV. These results established conclusive- 
ly that the chimeric receptor detects the cognate HEV-ligand 
of pnHR. We have, therefore, used the chimera to investigate 
if the effects of sialidase and LA on lymphocyte attachment 
to PN HEV could be attributed to direct effects on the PN 
HEV ligand.  As shown in Fig.  5, treatment of PN sections 
with  Vibrio cholera sialidase eliminated staining of HEV. 
Excess free sialic acid is known to inhibit the activity of this 
sialidase and was found to prevent the reduction in pnHR- 
IgG staining of PN HEV caused by sialidase (Fig. 5). Attin- 
ity-purified  Clostridium perfringens  sialidase,  also  previ- 
ously shown to prevent lymphocyte attachment to PN HEV 
(Rosen et al.,  1985),  similarly eliminated  staining  of PN 
HEV by the chimera (Fig.  5).  Finally,  in correspondence 
with the effect of LA on lymphocyte attachment to PN HEV, 
pretreatment of tissue sections with this lectin prevented the 
specific staining of PN HEV by the chimera (Fig.  5). 
Discussion 
Our  previous  work,  using  highly  specific bacterial  siali- 
dases, established a role for sialic acid moieties on PN HEV 
in the attachment of lymphocytes to these specialized blood 
vessels. Lymphocyte binding to HEV is thought to involve 
the concerted action of (at least) one organ-selective homing 
receptor  in  conjunction  with  general  accessory  adhesion 
molecule, such as LFA-1. Since there is the potential for mul- 
tiple adhesive ligands in this system, it was not clear whether 
sialic acid was required for the activity of the HEV-ligand of 
the homing receptor or an accessory adhesion molecule. The 
finding that the sialidase effects on HEV varied with the ana- 
tomical site of the lymphoid organ argued that the target of 
the enzyme on PN HEV was the HEV ligand itself rather than 
an  accessory  adhesion  molecule.  An  accessory  adhesion 
molecule, such as a ligand for LFA-1, would be predicted to 
be invariant among HEV at different sites. Here, we demon- 
strate directly that sialic acid is required for the interaction 
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Figure 4. Effects of sialidase pretreatment of PP sections on block- 
ade of HEV adhesive sites by L/max agglutinin. PP sections were 
pretreated with sialidase or with digestion buffer alone and then ex- 
posed to LA or to buffer. The sections were processed and tested 
for lymphocyte binding to HEV as described. Binding to HEV was 
normalized to a percentage of the control level of binding (no siali- 
dase treatment,  no LA). The absolute level of lymphocyte binding 
in control  samples was 13.2 lymphocytes/104 #m  2. 
True et al.  Sialic Acid and HEV Adhesive Function  2761 Figure 5. Effects of sialidases and L/max agglutinin on staining of PN HEV with pnHR-IgG chimera.  (Tbp) Sections of PN were treated with 
(a) digestion buffer; (b) Hbrio cholera sialidase; or (c) Hbrio cholera sialidase plus free sialic acid (100 raM). In the middle panel, sections 
were treated with (a) control digestion buffer or (b) Clostridium perfringens  sialidase. (Bottom) Sections were treated with (a) control buffer 
or (b) LA. After the above treatments, sections were stained with pnHR-IgG chimera or with desialylated chimera (LA experiment) in conjunc- 
tion with HRP histochemistry  to reveal the remaining HEV ligand. Arrows denote basement membranes of HEV in those sections where 
staining is greatly reduced.  Bars, 20/~m. 
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dase prevents staining of PN HEV by a soluble recombinant 
form ofpnHR. This conclusion is strengthened by the obser- 
vation that the sialic acid-specific lectin, LA, prevents both 
lymphocyte  binding to PN HEV and staining of PN HEV by 
the chimera. These effects are mediated by the sialic acid 
binding site on LA, as evidenced by the blocking effect of 
sialic acid on L,~s inhibition of lymphocyte attachment to 
HEV.  The selectivity of LA is indicated by the finding that 
a series of other lectins, several of which react with HEV, 
produced no effect on lymphocyte  attachment to HEV. It was 
surprising that two other sialic-acid binding lectins, WGA 
and limulin, did not affect lymphocyte attachment to PN- 
HEV. WG/~s lack of activity may be attributable to its rela- 
tively restricted range in binding sialyloligosaceharides. For 
example, WGA does not bind to N-glycolyl sialic acid, while 
LA recognizes this form of sialic acid as well as the more 
prevalent  N-acetyl  form  (Bhavanandan  and  Katlic,  1979; 
Ravindranath et al., 1985). Furthermore, WGA binds to sialy- 
lated neo-lacto glycosphingolipids  but fails to recognize brain 
gangliosides (Molin et al.,  1986),  while LA binds to both 
glycolipid classes (True,  D.  D.,  B.  A.  Macher, and S.  D. 
Rosen, in preparation). Perhaps, a crucial sialyloligosaccha- 
ride required for lymphocyte  binding to PN-HEV is not rec- 
ognized by WGA. The inactivity of limulin is more difficult 
to rationalize, since it demonstrates a binding specificity for 
sialic  acid which  overlaps  significantly with  LA  (Ravin- 
dranath et al.,  1985).  It is possible that limulin binding to 
PN HEV is weak, and the lectin is fluted prior to the addi- 
tion of lymphocytes in the in vitro adhesion assay. 
Conceivably,  the  critical  sialidase-  and  LA-susceptible 
sialic acid moieties of PN HEV reside on endothelial mole- 
cules that are physically associated with, and yet distinct 
from the HEV ligand. For example, it is known that the inter- 
action of complement factor H  with C3b on target mem- 
branes is positively modulated by sialic acid moieties present 
on membrane gangliosides (Michalek et al., 1989a,b). Since 
LA is of relatively low molecular mass, i.e., a dimer of 22- 
kD subunits (Miller et al., 1982), the critical sialylated sites, 
if separate from the HEV ligand, must be sterically very 
close to it.  If, as is more likely, the essential sialic acid 
residues are actually part of the HEV ligand, two distinct 
roles can be envisioned. One is an indirect role in which 
sialic acid moieties modulate the orientation or conforma- 
tion of a distal recognition site of the ligand. Alternatively, 
sialic acid moieties may directly contribute to an HEV ligand 
determinant that is engaged by the pnHR.  Supporting this 
latter possibility is the fact that the lectin domain of this 
receptor contains a large number of lysine residues (Lasky 
et al.,  1989;  Bowen et al.,  1989b),  16 in the case of the 
mouse molecule and 12 for the human. By contrast, other 
C-type lectin domains  (e.g.,  asialoglycoprotein receptors 
and mannose-binding receptors) contain significantly fewer 
lysines (an average of five for the family) and have only been 
found to recognize neutral sugars (Drickamer,  1988).  The 
ligand for the pnHR is not, however, a simple form of sialic 
acid, since Neu5Ac,  either as a free sugar or in the form of 
sialyllactose, is not an effective inhibitor of  the lectin activity 
of isolated gp90  MEL 0mai et al., 1990).  Since sialic acid oc- 
curs naturally in a multitude of different forms and in many 
linkages to a variety of sugars (Schauer,  1982;  1985),  the 
strong possibility remains that a distinctive sialyloligosac- 
charide may define the recognition determinant of the HEV 
ligand.  The  ability  of M6P,  FIP,  and  fucose-sulfate or 
galactose-sulfate containing glycoconjugates to interact with 
pnHR may reflect a structural mimicry between these sub- 
stances and the postulated sialyloligosaccharide. The exact 
role of sialic acid in the function of the PN HEV ligand, 
whether as a modulatory element or as part of a recognition 
determinant, awaits the isolation and structural analysis of 
the ligand. Candidates for the molecule already exist among 
the complex of  proteins recognized by MECA-79, a mAb that 
selectively stains PN HEV and blocks lymphocyte attach- 
ment (Streeter et al.,  1988b;  Berg et al.,  1989;  Butcher, 
1990). 
Previously, we reported that sialidases from V. cholera and 
C. perfringens do not inactivate lymphocyte  attachment sites 
on PP-HEV, and in unpublished experiments, Arthrobacter 
ureafaciens  sialidase is similarly inactive. These enzymes 
represent a broad range of activities against sialic acids bear- 
ing N-acetyl or glycolyl substitutions in ot2-3 or or2-6 link- 
ages to various sugars. Thus, it was surprising that LA in- 
hibited adhesive sites on PP HEV to the same extent as those 
on PN HEV.  As was the case for the PN, preincubation of 
LA with free Neu5Ac blocked its inhibitory effects on PP 
sites. Therefore, the sialic acid-binding activity of LA would 
appear to be directly implicated in its function-blocking ac- 
tivity on PP sites.  Yet, PP HEV treated with sialidase and 
lacking the majority of their LA-reactive sites, remain sus- 
ceptible to inhibition by LA. One explanation of  these appar- 
ently conflicting observations is that sialidase-resistant sialic 
acid residues,  comprising a  small percentage of the total 
sialylated structures, are the targets for the blocking activity 
of LA on PP HEV.  Among the many known modifications 
of sialic acid, several forms are resistant to bacterial siali- 
dases (Schauer, 1982). An intriguing possibility, compatible 
with the known capacity of sialyloligosaccharides to encode 
highly specific ligands for antibody recognition (Magnani, 
1987) and for microbial adhesive receptors (Paulson, 1985; 
Sharon and Lis, 1989; Wiley and Skehel, 1987),  is that dis- 
tinct sialyloligosaccharides constitute the organ-specific rec- 
ognition determinants of the HEV-ligands on both PN and 
PP. Implicit in this speculation is the prediction of a lectin- 
like homing receptor involved in lymphocyte attachment to 
Peyer's patch HEV. 
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